iOnctura awarded EUR17.5 million funding from the EIC Accelerator for clinical development of novel pancreatic cancer therapy ...Middle East

Funding will support iOnctura's clinical program for IOA-289, a first-in-class autotaxin inhibitor for the treatment of cancer AMSTERDAM, Dec. 20, 2022 /PRNewswire/ -- iOnctura BV, a clinical-stage biotech developing novel cancer therapies, announces today that it has been granted EUR17.5...

Hence then, the article about ionctura awarded eur17 5 million funding from the eic accelerator for clinical development of novel pancreatic cancer therapy was published today ( Tuesday 20/12/2022 - 01:40 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( iOnctura awarded EUR17.5 million funding from the EIC Accelerator for clinical development of novel pancreatic cancer therapy )

Also on site :

• Ernest James Lattimer arrested for multiple sex crimes involving children who were attending an in-home childcare facility on Emerald Way
• Bobby Bones Is Barely Recognizable After Rescuing a Stranger During Winter Storm Fern
• Who Is Anthony Kazmierczak? Ilhan Omar Attack Suspect Identified